| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/11/2006 | WO2006035414A3 Carbidopa and levodopa dispersible tablets |
| 05/11/2006 | WO2006034560A3 Prevention and treatment of mycoplasma-associated diseases |
| 05/11/2006 | WO2006034463A3 Herbal supplement to support weight loss |
| 05/11/2006 | WO2006032023A3 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 05/11/2006 | WO2006031720A3 D-methionine formulation with improved biopharmaceutical properties |
| 05/11/2006 | WO2006030450A3 Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy |
| 05/11/2006 | WO2006029385A3 Quinazoline derivatives as metabolically inert antifolate compounds. |
| 05/11/2006 | WO2006029018A3 Combinatorial chemotherapy treatment using na+/k+-atpase inhibitors |
| 05/11/2006 | WO2006027685A3 Glycosylceramide adjuvant for saccharide antigens |
| 05/11/2006 | WO2006023408A3 Method of customizing the fragrance of nasal medications |
| 05/11/2006 | WO2006019660A3 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane |
| 05/11/2006 | WO2006018280A3 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 05/11/2006 | WO2006018279A3 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 05/11/2006 | WO2006018019A3 SELECTIVE INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE TYPE 1 |
| 05/11/2006 | WO2006014282A3 Prodrugs of hiv protease inhibitors |
| 05/11/2006 | WO2006013546A3 Process for the preparation of pure galantamine |
| 05/11/2006 | WO2006001029A3 Antiretroviral compositions |
| 05/11/2006 | WO2005120520A8 Compositions and methods for diagnosis and treatment of chemotherapy-resistant neoplastic disease |
| 05/11/2006 | WO2005116212A3 Treatment of neurodegenerative disease through intracranial delivery of sirna |
| 05/11/2006 | WO2005115357A3 Taurolidine formulations and delivery |
| 05/11/2006 | WO2005115076A3 Combi-preparation of a green lipped mussel extract and a non-steroidal anti-inflammatory drug. |
| 05/11/2006 | WO2005110439A3 Stabilized hyaluronan preparations and related methods |
| 05/11/2006 | WO2005107808A3 Combination of atypical antipsychotics and 5-ht1b receptor antagonists |
| 05/11/2006 | WO2005106471A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 4 (ccr4) |
| 05/11/2006 | WO2005105061A3 Transdermal patch |
| 05/11/2006 | WO2005103039A8 2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists |
| 05/11/2006 | WO2005102390A3 Combinations comprising alpha-2-delta ligands and nmda receptor antagonists |
| 05/11/2006 | WO2005102275B1 Galantamine salts, method of producing it and nasal composition thereof |
| 05/11/2006 | WO2005101838A8 Piperazinylpiperidine derivatives as chemokine receptor antagonists |
| 05/11/2006 | WO2005099706A3 Muscarinic acetylcholine receptor antagonists |
| 05/11/2006 | WO2005089731A3 Use of renin inhibitors in therapy |
| 05/11/2006 | WO2005089728A3 Means for transdermal administration of nicotine |
| 05/11/2006 | WO2005086892A3 Ion channel modulators |
| 05/11/2006 | WO2005084440A8 Method for increasing muscle mass and strength through administration of adenosine triphosphate |
| 05/11/2006 | WO2005079797A3 Hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid |
| 05/11/2006 | WO2005079753A3 Extended release pharmaceutical compositions of divalproex sodium |
| 05/11/2006 | WO2005072082B1 2-guanidinylimidazolidinedione compounds and methods of making and using thereof |
| 05/11/2006 | WO2005065713A3 Topically applied medicament for animals |
| 05/11/2006 | WO2005065185A3 Temperature-stable formulations, and methods of development thereof |
| 05/11/2006 | WO2005058893A8 Tricyclic benzimidazoles |
| 05/11/2006 | WO2005051317A3 Substituted imidazo ring systems and methods |
| 05/11/2006 | WO2005045055A3 The use of plp with peg-rmetase in vivo for enhanced efficacy |
| 05/11/2006 | WO2005034912A3 Ferromagnetic particles and methods |
| 05/11/2006 | WO2005030209A8 Pyridine derivatives and use thereof as urotensin ii antagonists |
| 05/11/2006 | WO2005018551A3 Oxime substituted imidazo-containing compounds |
| 05/11/2006 | WO2005016250A3 Cell therapy for neurometabolic disorders |
| 05/11/2006 | WO2005012275A3 Benzo [1, 2, 5] thiadiazole compounds as cck2 modulators |
| 05/11/2006 | WO2005011645A8 Selected betaines and their uses |
| 05/11/2006 | WO2004110381A3 Pharmaceutical compositions comprising active vitamin d compounds |
| 05/11/2006 | WO2004096151A3 Methods and devices for the sustained release of multiple drugs |
| 05/11/2006 | WO2004066955A3 Slowly digestible starch |
| 05/11/2006 | WO2004056323A3 Method of treating angiogenic tissue growth |
| 05/11/2006 | WO2003091253A8 Nitrosated imidazopyridines |
| 05/11/2006 | WO2002098351A8 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 05/11/2006 | US20060100611 Controlled laser treatment for non-invasive tissue alteration, treatment and diagnostics with minimal collateral damage |
| 05/11/2006 | US20060100461 Acetamidobenzamide compounds for neurodegenerative disorders |
| 05/11/2006 | US20060100460 Substituted N-sulfonylaminobenzyl-2-phenoxyacetamide compounds as VR1 receptor agonists |
| 05/11/2006 | US20060100446 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/11/2006 | US20060100445 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/11/2006 | US20060100443 Valsartan benzyl ester is hydrolyzed with an excess alkali metal hydroxide; washed with an organic solvent; acidified and isolated |
| 05/11/2006 | US20060100442 Reacting 2-{[(S)-2-methylpent-4-in-1-yl]oxy}-3,4,5,6-tetrahydro-2H-pyrane with acetaldehyde to produce 2RS,6S)-6-Methyl-7-[(RS)-(3,4,5,6-tetrahydro-2H-pyran-2-yl)oxy]hept-3-in-2-ol |
| 05/11/2006 | US20060100437 Process for producing carbostyril derivatives |
| 05/11/2006 | US20060100436 Antimicrobial quinolones, their compositions, and uses |
| 05/11/2006 | US20060100427 Alzheimer's disease and other diseases relating to amyloid deposits; neurodegenerative diseases |
| 05/11/2006 | US20060100291 Antibacterial compounds |
| 05/11/2006 | US20060100290 Treatment of allergic rhinitis and asthma |
| 05/11/2006 | US20060100289 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| 05/11/2006 | US20060100288 Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential |
| 05/11/2006 | US20060100287 Insulin-like growth factor-1 secretagogue |
| 05/11/2006 | US20060100286 Treatment of canine hemangiosarcoma with a histone deacetylase inhibitor |
| 05/11/2006 | US20060100285 N-hydroxy-4-[2-(4-trifluoromethyl-phenyl)-acetylamino]-benzamide for example; treating infammatory, autoimmune diseases, tumors, and neurodegenerative diseases |
| 05/11/2006 | US20060100284 Growth promotor |
| 05/11/2006 | US20060100283 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof |
| 05/11/2006 | US20060100282 Novel diaminopropane-based metal chelators as antiviral agents |
| 05/11/2006 | US20060100281 Method of treating tinnitus |
| 05/11/2006 | US20060100280 Cell growth regulator |
| 05/11/2006 | US20060100279 Culturing heterotrophic microalgae of the class Dinophyceae in a culture medium, wherein the culture medium has a pH of less than about 6.0, wherein the microalgae produce at least about 0.04 g DHA per liter of 7-day culture |
| 05/11/2006 | US20060100278 Dosage forms and related therapies |
| 05/11/2006 | US20060100277 Antibiotics cyan-416 a, cyan-416 b, cyan-416 c, cyan-416 d and cyan-416 e, and ester derivatives of cyan-416 b |
| 05/11/2006 | US20060100276 Method of treating neutrophil-related diseases with topical anesthetics |
| 05/11/2006 | US20060100275 Phenoxyacetic acid derivative e.g. ethyl (-)-2-[4-[2-[[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-2,5-dimethylphenoxy]acetate hydrochloride; selective beta 3-adrenoceptor stimulator; capsaicin-sensitive sensory nerve inhibitor; pain |
| 05/11/2006 | US20060100274 Therapeutic avenanthramide compounds |
| 05/11/2006 | US20060100273 Anhydrous silver dihydrogen citrate compositions |
| 05/11/2006 | US20060100272 Formulations for the treatment of pain |
| 05/11/2006 | US20060100271 Stabilized aqueous ranitidine compositions |
| 05/11/2006 | US20060100270 Methods for preventing, attenuating or treating pulmonary hypertension using a serotonin transporter inhibitor, and pharmaceutical compositions for the treatment thereof |
| 05/11/2006 | US20060100269 Use of 10-aminoaliphatyl-dibenz[b,f]oxepines for the treatment of degenerative ocular disorders |
| 05/11/2006 | US20060100268 Method of treating atherosclerosis or restenosis using microtube stabilizing agent |
| 05/11/2006 | US20060100267 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/11/2006 | US20060100266 3-(2-Dimethylaminoethyl)-7-fluoro-1-methyl-1H-indol-4-ol; Obsessive Compulsive Disorder; appetite suppressants |
| 05/11/2006 | US20060100265 4-(1-(sulfonyl)-1h-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents |
| 05/11/2006 | US20060100264 3,3'-Diindolylmethane immune activating compositions |
| 05/11/2006 | US20060100263 Antipyretic compositions and methods |
| 05/11/2006 | US20060100262 Tetracyclic indole derivatives as antiviral agents |
| 05/11/2006 | US20060100261 Furan or thiopene derivative and medicinal use thereof |
| 05/11/2006 | US20060100259 Process for the preparation of substituted triazole compounds |
| 05/11/2006 | US20060100258 Growth promotion method |
| 05/11/2006 | US20060100257 Inhibitors against the activation of ap-1 and nfat |
| 05/11/2006 | US20060100256 Reacting bromine with an aqueous solution of 4-acetamidocyclohexanone to produce 2-bromo-4-acetamidocyclohexanone; adding thiourea to produce 6-acetylamino-2-amino-4,5,6,7-tetrahydrobenzothiazole; and cleaving the acetyl group with hydrobromic acid; forming pramipexole by reaction with a propionyl halide |
| 05/11/2006 | US20060100255 Substituted indolealkanoic acids derivative and formulations containing same for use in the treatment of diabetic complications |